Mapping CSC-Mediated Ovarian Cancer Chemoresistance via CXCR4-PET to Guide Precision Cisplatin Re-Sensitization

Lixia Feng1,2,3,4, Simei Zhao1, Zheng Wei5

  • 1Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Insights

Targeting CXC motif chemokine receptor 4 (CXCR4) in ovarian cancer stem cells (CSCs) shows promise. CXCR4 blockade and imaging can improve chemoresistance treatment and reduce relapse risks in ovarian cancer patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Medical Imaging

Background:

  • Targeting cancer stem cells (CSCs) is crucial for overcoming chemoresistance and relapse in ovarian cancer (OC).
  • Identifying targetable markers for ovarian CSCs remains a significant challenge in OC research.
  • CXC motif chemokine receptor 4 (CXCR4) is investigated as a potential functional marker for ovarian CSCs.

Purpose of the Study:

  • To evaluate CXCR4 as a targetable marker for ovarian CSCs.
  • To develop a translational model for CXCR4-targeted imaging and therapy in OC.
  • To assess the efficacy of CXCR4 blockade in combination with chemotherapy.

Main Methods:

  • Analysis of CXCR4 expression in chemoresistant ovarian CSC-like cells.
  • In vitro and in vivo assessment of self-renewal capacity and chemoresistance.
  • Administration of CXCR4 inhibitor AMD3100 and cisplatin (CDDP).
  • Positron emission tomography (PET) imaging using CXCR4-targeted [68Ga]Ga-Pentixafor.

Main Results:

  • CXCR4 was identified as a potential stemness marker in ovarian CSCs, correlating with self-renewal and chemoresistance.
  • AMD3100 impaired CSC self-renewal and enhanced cisplatin sensitivity.
  • [68Ga]Ga-Pentixafor PET imaging accurately delineated CXCR4-high tumors in xenografts and patient-derived models.
  • Combination therapy of AMD3100 and CDDP showed significant antitumor effects in CXCR4-high tumors but not in CXCR4-low tumors.

Conclusions:

  • CXCR4 represents a functional CSC marker associated with chemoresistance in ovarian cancer.
  • CXCR4-targeted PET imaging can guide the selection of patients for AMD3100 therapy.
  • This approach holds potential for clinical translation in managing ovarian cancer.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Uncertainty in Measurement: Accuracy and Precision03:37

Uncertainty in Measurement: Accuracy and Precision

Scientists typically make repeated measurements of a quantity to ensure the quality of their findings and to evaluate both the precision and the accuracy of their results. Measurements are said to be precise if they yield very similar results when repeated in the same manner. A measurement is considered accurate if it yields a result that is very close to the true or the accepted value. Precise values agree with each other; accurate values agree with a true value. 
101.8K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
4.0K
Accuracy and Precision01:52

Accuracy and Precision

Scientists typically make repeated measurements of a quantity to ensure the quality of their findings and to evaluate both the precision and the accuracy of their results. Measurements are said to be precise if they yield very similar results when repeated in the same manner. A measurement is considered accurate if it yields a result that is very close to the true or the accepted value. Precise values agree with each other; accurate values agree with a true value.  Highly accurate...
15.5K